Biofilms as "connectors" for Oral and Systems Medicine: A New Opportunity for Biomarkers, Molecular Targets, and Bacterial Eradication

OMICS A Journal of Integrative Biology

Volumn 20, Issue 1, 2016, Pages 3-11

  Sintim, Herman O ^a,b   Gürsoy, Ulvi Kahraman ^c  

^a University of Maryland   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ARTICLE; BACTERIAL CLEARANCE; BACTERIUM COLONY; BIOFILM; DIGESTIVE SYSTEM; GINGIVA; MICROORGANISM; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; RNA SEQUENCE; SYSTEMIC DISEASE; BIOMASS; METABOLISM;

BIOFILMS; BIOMARKERS; BIOMASS;

EID: 84954538477     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2015.0146     Document Type: Article

References (89)

1. Abiko Y, Saitoh M. (2007). Salivary defensins and their importance in oral health and disease. Curr Pharm Des 13, 3065-3072.
2. Aruni AW, Dou Y, Mishra A, Fletcher HM. (2015). The biofilm community-Rebels with a cause. Curr Oral Health Rep 2, 48-56.
3. Asadoorian J, Williams K. (2008). Cetylpyridinium chloride mouth rinse on gingivitis and plaque. J Dent Hyg 82, 1-5.
4. Asahi Y, Noiri Y, Igarashi J, Asai H, Suga H, Ebisu S. (2010). Effects of N-acyl homoserine lactone analogues on Porphyromonas gingivalis biofilm formation. J Periodont Res 45, 25599261.
5. Asahi Y, Noiri Y, Igarashi J, Suga H, Azakami H, Ebisu S. (2012). Synergistic effects of antibiotics and an N-acyl homoserine lactone analog on Porphyromonas gingivalis biofilms. J Appl Microbiol 112, 404-411.
6. Bae K, Jun EJ, Lee SM, Paik DI, Kim JB. (2006). Effect of water-soluble reduced chitosan on Streptococcus mutans, plaque regrowth and biofilm vitality. Clin Oral Investig 10, 102-107.
7. Beikler T, Flemmig TF. (2011). Oral biofilm-associated diseases: Trends and implications for quality of life, systemic health and expenditures. Periodontol 2000 55, 87-103.
8. Bowler RP, Bahr TM, Hughes G, Lutz S, Kim YI, Coldren CD, Reisdorph N, Kechris KJ. (2013). Integrative omics approach identifies interleukin-16 as a biomarker of emphysema. OMICS 17, 619-626.
9. Brown SA, Whiteley M. (2007). A novel exclusion mechanism for carbon resource partitioning in Aggregatibacter actinomycetemcomitans. J Bacteriol 189, 6407-6414.
10. Cheung HY, Wong MM, Cheung SH, Liang LY, Lam YW, Chiu SK. (2012). Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli. PLoS One 7, e36659.
11. Chung JY, Choo JH, Lee MH, Hwang JK. (2006). Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine 13, 261-266.
12. Coburn RA, Batista AJ, Evans RT, Genco RJ. (1981). Potential alicylamide antiplaque agents. In vitro antibacterial activity against Actinomyces viscosus. J Med Chem 24, 1245-1249.
13. Dandara C, Huzair F, Borda-Rodriguez A, et al. (2014). H3Africa and the African life sciences ecosystem: Building sustainable innovation. OMICS 18, 733-739.
14. Dawes C, Pedersen AM, Villa A, et al. (2015). The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI. Arch Oral Biol 60, 863-874.
15. Diaz PI, Zilm PS, Rogers AH. (2002). Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments. Microbiology 148, 467-472.
16. Duarte S, Gregoire S, Singh AP, et al. (2006). Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 257, 50-56.
17. Egland PG, Dû LD, Kolenbrander PE. (2001). Identification of independent Streptococcus gordonii SspA and SspB functions in coaggregation with Actinomyces naeslundii. Infect Immun 69, 7512-7516.
18. ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. (2014). Pharmacomicrobiomics: The impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18, 402-414.
19. Ellse L, Wall R. (2014). The use of essential oils in veterinary ectoparasite control: A review. Med Vet Entomol 28, 233-243.
20. Filoche SK, Soma K, Sissons CH. (2005). Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol 20, 221-225.
21. Flemming HC, Wingender J. (2010). The biofilm matrix. Nat Rev Microbiol 8, 623-633.
22. Frias J, Olle E, Alsina M. (2001). Periodontal pathogens produce quorum sensing signal molecules. Infect Immun 69, 3431-3434.
23. Furuichi Y, Ramberg P, Lindhe J, Nabi N, Gaffar A. (1996). Some effects of mouthrinses containing salifluor on de novo plaque formation and developing gingivitis. J Clin Periodont 23, 795-802.
24. Guggenheim B, Giertsen E, Schupbach P, Shapiro S. (2001). Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 80, 363-370.
25. Gursoy UK, Pollanen M, Kononen E, Uitto VJ. (2010). Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model. J Periodontol 81, 1084-1091.
26. Hale JD, Ting YT, Jack RW, Tagg JR, Heng NC. (2005). Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: Elucidation of the antimicrobial repertoire by genetic dissection. Appl Environ Microbiol 71, 7613-7617.
27. Hannah JJ, Johnson JD, Kuftinee MM. (1989). Long-term evaluation of toothpaste and oral rinse containing sanguinaria extract in controlling plaque and gingival inflammation and sulcular bleeding during orthodontic treatment. Am J Orthod Maxillofac Orthopaed 96, 199-207.
28. Holmberg K, Hallander HO. (1973). Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis. Arch Oral Biol 18, 423-434.
29. Hyde ER, Luk B, Cron S, et al. (2014). Characterization of the rat oral microbiome and the effects of dietary nitrate. Free Radic Biol Med 77, 249-257.
30. Ingram GS, Horay CP, Stead WJ. (1992). Interaction of zinc with dental mineral. Caries Res 26, 248-253.
31. Islam B, Khan SN, Haque I, Alam M, Mushfiq M, Khan AU. (2008). Novel anti-adherence activity of mulberry leaves: Inhibition of Streptococcus mutans biofilm by 1-deoxynojirimycin isolated from Morus alba. J Antimicrob Chemother 62, 751-757.
32. Iwami Y, Schachtele CF, Yamada T. (1995). Mechanism of inhibition of glycolysis in Streptococcus mutans NCIB 11723 by chlorhexidine. Oral Microbiol Immunol 10, 360-364.
33. Jang YJ, Choi YJ, Lee SH, Jun HK, Choi BK. (2013). Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens. Arch Oral Biol 58, 17-27.
34. Jakubovics NS, Kolenbrander PE. (2010). The road to ruin: The formation of disease-associated oral biofilms. Oral Dis 16, 729-739.
35. Jones CG. (1997). Chlorhexidine: Is it still the gold standard Periodontol 2000 15, 55-56.
36. Kang MS, Oh JS, Kang IC, Hong SJ, Choi CH. (2008). Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J Microbiol 46, 744-750.
37. Karaosmanoglu K, Sayar NA, Kurnaz IA, Akbulut BS. (2014). Assessment of berberine as a multi-target antimicrobial: A multi-omics study for drug discovery and repositioning. OMICS 18, 42-53.
38. Kolenbrander PE, Palmer RJ Jr, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI. (2006). Bacterial interactions and successions during plaque development. Periodontol 2000 42, 47-79.
39. Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS. (2010). Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8, 471-480.
40. Kononen E, Wade WG. (2015). Actinomyces and related organisms in human infections. Clin Microbiol Rev 28, 419-442.
41. Kozai K, Miyake Y, Kohda H, et al. (1987). Inhibition of glucosyltransferase from Streptococcus mutans by oleanolic acid and ursolic acid. Caries Res 21, 104-108.
42. Kunze B, Reck M, Dotsch A, et al. (2010). Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol 10, 199.
43. Lankester J, Patel C, Cullen MR, Ley C, Parsonnet J. (2013). Urinary triclosan is associated with elevated body mass index in NHANES. PLoS One 8, e80057.
44. Li YH, Lau PC, Lee JH, Ellen RP, Cvitkovitch DG. (2001). Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol 183, 897-908.
45. Li YH, Tang N, Aspiras MB, et al. (2002). A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J Bacteriol 184, 2699-2708.
46. Lima BA, de Lira SP, Kossuga MH, Goncąlves RB, Berlinck RGS, Kamiyaf RU. (2014). Halistanol sulfate A and rodriguesines A and B are antimicrobial and antibiofilm agents against the cariogenic bacterium Streptococcus mutans. Rev Bras Farmacogn 24, 651-659.
47. Loesche WJ, Grossman NS, Earnest R, Corpron R. (1984). The effect of chewing xylitol gum on the plaque and saliva levels of Streptococcus mutans. J Am Dent Assoc 108, 587-592.
48. Loo WTY, Jin LJ, Cheung MNB, Chow LWC. (2010). Evaluation of ellagic acid on the activities of oral bacteria with the use of adenosine triphosphate (ATP) bioluminescence assay. Afr J Biotechnol 9, 3938-3943.
49. LoVetri K, Madhyastha S. (2010). Antimicrobial and antibiofilm activity of quorum sensing peptides and peptide analogues against oral biofilm bacteria. Methods Mol Biol 618, 383-392.
50. Lundberg JO, Weitzberg E, Gladwin MT. (2008). The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7, 156-167.
51. Marquis RE. Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol 1995, 41, 955-964.
52. Marsh PD, Bradshaw DJ. (1993). Microbiological effects of new agents in dentifrices for plaque control. Int Dent J 43, 399-406.
53. Mashburn-Warren L, Morrison DA, Federle MJ. (2010). A novel double-tryptophan peptide pheromone is conserved in mutans and pyogenic Streptococci and controls competence in Streptococcus mutans via an Rgg regulator. Mol Microbiol 78, 589-606.
54. McDonnell G, Russell AD. (1999). Antiseptics and disinfectants: Activity, action, resistance. Clin Microbiol Rev 12, 147-179.
55. Merritt J, Niu G, Okinaga T, Qi F. (2009). Autoaggregation response of Fusobacterium nucleatum. Appl Environ Microbiol 75, 7725-7733.
56. Murugan K, Sekar K, Sangeetha S, Ranjitha S, Sohaibani SA. (2013). Antibiofilm and quorum sensing inhibitory activity of Achyranthes aspera on cariogenic Streptococcus mutans: An in vitro and in silico study. Pharm Biol 51, 728-736.
57. Nakahara K, Kawabata S, Ono H, et al. (1993). Inhibitory effect of oolong tea polyphenols on glycosyltransferases of mutans Streptococci. Appl Environ Microbiol 59, 968-973.
58. Okuda T, Kokubu E, Kawana T, Saito A, Okuda K, Ishihara K. (2012). Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species. Anaerobe 18, 110-116.
59. Pandit S, Kim HJ, Park SH, Jeon JG. (2012). Enhancement of fluoride activity against Streptococcus mutans biofilms by a substance separated from Polygonum cuspidatum. Biofouling 28, 279-287.
60. Paul KB, Thompson JT, Simmons SO, Vanden Heuvel JP, Crofton KM. (2013). Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors. Toxicol In Vitro 27, 2049-2060.
61. Petersen FC, Fimland G, Scheie AA. (2006). Purification and functional studies of a potent modified quorum-sensing peptide and a two-peptide bacteriocin in Streptococcus mutans. Mol Microbiol 61, 1322-1334.
62. Potera C. (1999). Forging a link between biofilms and disease. Science 283, 1839.
63. Qi F, Kreth J, Levesque CM, et al. (2005). Peptide pheromone induced cell death of Streptococcus mutans. FEMS Microbiol Lett 25, 321-326.
64. Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. (2015a). Biofilm formation mechanisms and targets for developing anti-biofilm agents. Future Med Chem 7, 493-512.
65. Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. (2015b). Agents that inhibit bacterial biofilm formation. Future Med Chem 7, 647-671.
66. Rickard AH, Campagna SR, Kolenbrander PE. (2008). Autoinducer-2 is produced in saliva-fed flowconditions relevant to natural oral biofilms. J Appl Microbiol 105, 2096-2103.
67. Rickard AH, Palmer RJ Jr, Blehert DS, et al. (2006). Autoinducer 2: A concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol 60, 1446-1456.
68. Rosan B, Lamont RJ. (2000). Dental plaque formation. Microbes Infect 2, 1599-1607.
69. Ruiz-Linares M, Ferrer-Luque CM, Arias-Moliz T, de Castro P, Aguado B, Baca P. (2014). Antimicrobial activity of alexidine, chlorhexidine and cetrimide against Streptococcus mutans biofilm. Ann Clin Microbiol Antimicrob 13, 41.
70. Rukayadi Y, Hwang JK. (2006). In vitro activity of xanthorrhizol against Streptococcus mutans biofilms. Lett Appl Microbiol 42, 400-404.
71. Russell RR. (1979). Glucan-binding proteins of Streptococcus mutans serotype c. J Gen Microbiol 112, 197-201.
72. Saenz GC, Rao D, Underwood A, et al. (2012). Autoinducer-2 influences interactions amongst pioneer colonizing streptococci in oral biofilms. Microbiol 158, 1783-1795.
73. Sato Y, Yamamoto Y, Kizaki H. (1997).Cloning and sequence analysis of the gbpC gene encoding a novel glucan-binding protein of Streptococcus mutans. Infect Immun 65, 668-675.
74. Scheres N, Lamont RJ, Crielaard W, Krom BP. (2015). LuxS signaling in Porphyromonas gingivalis-host interactions. Anaerobe 35, 3-9.
75. Seneviratne CJ, Wang Y, Jin L, Wong SS, Herath TD, Samaranayake LP. (2012). Unraveling the resistance of microbial biofilms: Has proteomics been helpful Proteomics 12, 651-665.
76. Shao H, Lamont RJ, Demuth DR. (2007). Autoinducer 2 is required for biofilm growth of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Infect Immun 75, 4211-4218.
77. Sharma NC, Galustians HJ, Qaqish J, Charles CH, Vincent JW, McGuire JA. (2003). Antiplaque and antigingivitis effectiveness of a hexetidine mouthwash. J Clin Periodontol 30, 590-594.
78. Sharma S, Khan IA, Ali I, et al. (2009). Evaluation of the antimicrobial, antioxidant, anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother 53, 216-222.
79. Smith D J, Akita H, King WF, Taubman MA. (1994). Purification and antigenicity of a novel glucan-binding protein of Streptococcus mutans. Infect Immun 62, 2545-2552.
80. Suntharalingam P, Cvitkovitch DG. (2005). Quorum sensing in streptococcal biofilm formation. Trends Microbiol 13, 3-6.
81. Takahashi N. (2003). Acid-neutralizing activity during amino acid fermentation by Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol Immunol 18:109-113.
82. Tsumori H, Kuramitsu H. (1997). The role of the Streptococcus mutans glucosyltransferases in the sucrose-dependent attachment to smooth surfaces: Essential role of the gtfC enzyme. Oral Microbiol Immunol 12, 274-280.
83. Waaler SM, Rolla G. (1980). Plaque inhibition effect of combinations of chlorhexidine with metal ions zinc and tin. Acta Odont Scand 38: 213-217.
84. Wennstrom J, Lindhe J. (1979). Effect of hydrogen peroxide on developing plaque and gingivitis in man. J Clin Periodontol 6, 115-130.
85. Whitmore SE, Lamont RJ. (2014). Oral bacteria and cancer. PLoS Pathog 10, e1003933.
86. Yanti, Rukayadi Y, Kim KH, Hwang JK. (2008). In vitro anti-biofilm activity of macelignan isolated from Myristica fragrans Houtt. against oral primary colonizer bacteria. Phytother Res 22, 308-312.
87. Yanti, Rukayadi Y, Lee KH, Hwang JK. (2009). Activity of panduratin A isolated from Kaempferia pandurata Roxb. against multi-species oral biofilms in vitro. J Oral Sci 51, 87-95.
88. Yeung MK. (1999). Molecular and genetic analyses of Actinomyces spp. Crit Rev Oral Biol Med 10, 120-138.
89. Zeidan-Chulia F, Gursoy M, de Oliveira BH, et al. (2014). Focused microarray analysis of apoptosis in periodontitis and its potential pharmacological targeting by carvacrol. Arch Oral Biol 59, 461-469.